Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A STUDY OF SUPERIOR VENA CAVA OBSTRUCTION SYNDROME.

ABSTRACT: Superior vena cava obstruction syndrome was studied in 22 patients with a view to assess the etiological pattern and clinical profile. It was found that 4 patients (18.1%) had benign disease and the remaining 18 (81.9%) patients had malignancy. In 13 patients (59.9%) obstruction occurred due to bronchogenic carinoma. No complications occurred with invasive diagnostic procedures. All heavy smokers (59.9%) were found to have malignancy. Normal lung fields on chest radiography and CT scan with superior vena obstruction syndrome suggested benign disease in 2 cases.

SUBMITTER: Rosha D

PROVIDER: S-EPMC5530844 | biostudies-other | 1997 Apr

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

Diathermy-assisted recanalization of chronic superior vena cava obstruction, case report.

Project description:The number of cases of superior vena cava syndrome (SVCS) increased due to increased cardiac devices and central venous catheters. Management of benign SVCS is still controversial. A 51-year-old male known to have ischemic cardiomyopathy and chronic renal failure on regular hemodialysis. In the last 12 months, he had progressive shortness of breath and swelling of his upper part of the body. Examination revealed engorgement of the neck veins, facial puffiness, and pitting edema of both upper limbs. Venography showed occluded SVC. We applied a 50 Watt of energy via electrocautery pen to a Hi-Torque 0.014 Astato guidewire to cross the occluded segment retrogradely. We used 2 stents 39 mm, mounted on BIB 20/40 mm. Final angiography revealed full restoration of SVC flow. Diathermy use to cross a chronic total SVC obstruction is feasible and safe. Endovascular techniques are suitable as initial management of benign SVC syndrome.

| S-EPMC7283972 | biostudies-literature

Superior vena cava reconstruction and implantation of a leadless pacemaker for management of pacemaker-induced superior vena cava syndrome.

Project description: Not available

| S-EPMC6926231 | biostudies-literature

A transudative chylothorax associated with superior vena cava syndrome.

Project description:The chylothorax is a lymphocyte predominant protein-discordant exudative pleural effusions with low lactate dehydrogenase and elevated triglyceride levels. Transudative chylothoraces associated with Superior Cava syndrome (SVC) are an extremely rare clinical entity. In this manuscript, we describe a case of transudative chylothorax due to SVC obstruction secondary to thrombosis of a peripheral inserted central venous catheter, which ultimately resolved after endovascular intervention. In our review of the literature, only five cases of transudative chylothorax associated with SVC syndrome were identified with 60% of cases associated with thrombosis and complications due to catheters in the central venous circulation. Treatment of the underlying cause is key to resolution of the chylothorax. Thoracentesis is an initial intervention for diagnostic and therapeutic purposes. Endovascular intervention is the primary mode of treatment for SVC thrombosis and stenting is preferred for malignant causes, however anticoagulation alone has been reported in the resolution of chylothorax. In patients with recurrent chylothorax despite of relief of SVC obstruction, a medium-chain triglyceride diet and octreotide can be prescribed in order to decrease the chyle flow in the thoracic duct. Surgical ligation of the thoracic duct can be considered if medical management and endovascular treatment fails.

| S-EPMC6626116 | biostudies-literature

Absent right superior vena cava.

Project description:A patient planned to be performed catheter ablation. However, three-dimensional contrast-enhanced chest computed tomography revealed isolated persistent left superior vena cava. We should know such an anatomical abnormality especially when central venous catheter or peripherally inserted central catheter is inserted from right jugular vein or right subclavian vein.

| S-EPMC8245746 | biostudies-literature

Venous bifurcation stenting for pacemaker-induced superior vena cava syndrome.

Project description: Not available

| S-EPMC8307697 | biostudies-literature

Aortic valve endocarditis with root abscess causing superior vena cava obstruction: a case report.

Project description:Background:To our knowledge, we report the first case of endocarditis with root abscess causing compressive superior vena cava (SVC) obstruction. Case summary:An 84-year-old gentleman with previous tissue aortic valve replacement presented with fevers and systemic upset. Blood cultures grew Streptococcus anginosus and transoesophageal echocardiogram identified prosthetic valve vegetations with an associated root abscess. Antibiotics were commenced and referral made for surgical consideration. Several days into treatment the patient developed clinical signs of SVC obstruction and computed tomography demonstrated an enlarging root abscess with SVC compression. The patient was discussed with local cardiothoracic centres, but surgery was not an option primarily due to abscess size and vascular involvement. Priority moved from active to palliative treatment given no improvement with antibiotics, unsuitability for surgery, and patient discomfort. Within several weeks, symptoms/signs of SVC obstruction actually improved, likely due to collateral venous circulation formation and the patient was discharged home with palliative care input. Discussion:There are previous reports of SVC obstruction related to infected SVC thrombus, indwelling intravascular devices, and para-aortic abscess, but none related to infective endocarditis. Streptococcus anginosus endocarditis is rare but often associated with abscess formation, and male gender, increasing age, and previous surgery are recognized risk factors.

| S-EPMC6939814 | biostudies-literature

Iatrogenic superior vena cava syndrome from percutaneous right ventricular assist device.

Project description: Not available

| S-EPMC8300479 | biostudies-literature

Reconstruction of the superior vena cava with an autologous pericardial patch for a giant superior vena cava aneurysm.

Project description: Not available

| S-EPMC8308190 | biostudies-literature

Palliative treatment of superior vena cava syndrome with nitinol stents.

Project description:This study aims to retrospectively evaluate the outcomes following nitinol stent placement for malignant superior vena cava syndrome. A total of 25 patients with thoracic malignancies were treated with self-expanding nitinol stents for superior vena cava syndrome (E*Luminexx [Bard GmbH/Angiomed, Karlsruhe, Germany], Sinus-XL [OptiMed Medizinische Instrumente GmbH, Ettlingen, Germany], and Zilver Vena [Cook Medical Inc., Bloomington, IN]). It was seen that the procedural success rate was 76% with all stents deployed as intended and no procedure-related complications but in five patients with 50% residual stenosis and one patient with stent occlusion within 48 hours after stent deployment. Stent occlusion occurred in further two patients during follow-up: one patient developed infection, thrombosis, and occlusion in the stent seen at 2-month follow-up, and one patient had stent occlusion at 4-month follow-up. The clinical success rate was 96%. Stent compression leading to a greater than 50% reduction in stent diameter was observed in three patients at follow-up. Overall 22 patients died at a mean follow-up of 3.5 months for reasons related to their underlying malignancy. It was concluded that the stent treatment for superior vena cava syndrome is a safe treatment with good clinical effect in patients with superior vena cava syndrome in the terminal phase of malignant disease. In this small patient population, no trends were observed which would suggest that outcomes vary by stent type, though additional, large-scale studies are needed.

| S-EPMC4244246 | biostudies-other

Persistent Left Superior Vena Cava Associated with an Anomalous Drainage of Right Superior Vena Cava into the Left Atrium.

Project description: Not available

| S-EPMC8326212 | biostudies-literature